ReBalance Füsioteraapia OÜ

Active Registry code 17010729 OÜ Pärnu linn Registered 17 Jun 2024
Compare

ReBalance Füsioteraapia OÜ is a OÜ based in Pärnu linn, registry code 17010729, status: active. Main activity: Other human health activities n.e.c.. Its annual report for 2025 shows revenue of €0 and 0 employees.

Revenue
0 €
↓ 100.0% vs 2024
Employees
0
±0 vs 2024

2025 · annual report, e-Äriregister

Position in the industry Human health activities · EMTAK 86

  • Revenue · 2025 0 €
    industry median 20 811 € · companies in the industry: 3 373

Taxes and turnover

No tax data available. EMTA publishes data for those who paid state taxes, filed a VAT return or had employees in the quarter. New and small companies may be missing.

Financials by year

2024 – 2025
Revenue, € 2025: 0 € · −100.0% vs 2024 · industry median 20 811 € · above 5% of the industry
05 00010 00015 00020 00025 0002024 Company: 1 575 € Industry median: 20 000 €20242025 Company: 0 € Industry median: 20 811 €202505 00010 00015 00020 00025 0002024 Company: 1 575 € Industry median: 20 000 €2025 Company: 0 € Industry median: 20 811 €2025
  • Company
  • Industry median

Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit, € 2025: 24 € · +2 500.0% vs 2024 · industry median 1 071 € · above 36% of the industry
-50005001 0001 5002 0002024 Company: -1 € Industry median: 1 621 €20242025 Company: 24 € Industry median: 1 071 €2025-50005001 0001 5002 0002024 Company: -1 € Industry median: 1 621 €2025 Company: 24 € Industry median: 1 071 €2025
  • Company
  • Industry median

Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit margin, % 2024: -0.1 % · industry median 10.7 % · above 22% of the industry
-3035810132024 Company: -0.1 % Industry median: 10.7 %20242025 Company: — Industry median: 8.3 %2025-3035810132024 Company: -0.1 % Industry median: 10.7 %2025 Company: — Industry median: 8.3 %2025
  • Company
  • Industry median

Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Assets, € 2025: 25 € · +0.0% vs 2024
05101520252024 Company: 25 €20242025 Company: 25 €202505101520252024 Company: 25 €2025 Company: 25 €2025
Equity, € 2025: 25 € · +2 400.0% vs 2024
05101520252024 Company: 1 €20242025 Company: 25 €202505101520252024 Company: 1 €2025 Company: 25 €2025
Employees 2025: 0 · industry median 2 · above 2% of the industry
0.00.51.01.52.02024 Company: 0 Industry median: 220242025 Company: 0 Industry median: 220250.00.51.01.52.02024 Company: 0 Industry median: 22025 Company: 0 Industry median: 22025
  • Company
  • Industry median

Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Financials by year
Year Revenue, € Net profit, € Labour costs, € Assets, € Equity, € Employees
2025 0 24 0 25 25 0
2024 1 575 -1 0 25 1 0

Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.

Financial ratios for 2025

Return on equity (ROE)
96.0 %
Net profit / equity
Return on assets (ROA)
96.0 %
Net profit / assets
Equity ratio
100.0 %
Equity / assets
Debt ratio
0.0 %
Liabilities / assets

Annual reports

PDFs from e-Äriregister
Annual reports
Year Period Filed Report Documents
2025 1 Jan 2025 – 31 Dec 2025 30 Jun 2026 Company’s own e-Äriregister
2024 17 Jun 2024 – 31 Dec 2024 3 Jul 2025 Company’s own e-Äriregister

Board

Right of representation

Any member of the management board may represent the private limited company in all transactions.

Owners

Beneficial owners

Founders and other persons

Activities (EMTAK)

  • 86992Other human health activities n.e.c. Main
Rulings
Number, date Title Deadline State Document
Ä 50257800 / 2
28 Sep 2024
Amendment entry In force
28 Sep 2024
PDF
Ä 50257800
17 Jun 2024
First entry In force
17 Jun 2024
PDF

Sources: e-Äriregister and EMTA. Data updated 2 Nov 2026. Open at the source ↗ · Report an error in the data